Chirag R. Parikh - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLXY)

Role
Director
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
RNLXY
Transactions as of
01 Jul 2023
Net transactions value
$0
Form type
3
Filing time
03 Jul 2023, 16:23:42 UTC
Next filing
22 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNLX Stock Option (right to buy) 01 Jul 2023 Ordinary Shares 65,724 Direct F1, F2
holding RNLX Stock Option (right to buy) 01 Jul 2023 Ordinary Shares 50,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 The exercise price is 1.21 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.53 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).
F3 The exercise price is 2.51 pounds sterling. The U.S. dollar equivalent of the exercise price is $3.17 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney